|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2008-3-25
|
|
pubmed:abstractText |
Adjuvant aromatase inhibitors (AIs), instead of or after tamoxifen, are effective in decreasing recurrence in postmenopausal women with estrogen receptor (ER)-positive breast cancer. An understanding of which patients are at risk of early recurrence while they are receiving tamoxifen may improve clinical decision making.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0008-543X
|
|
pubmed:author |
pubmed-author:BajdikChrisC,
pubmed-author:BarnettJeffJ,
pubmed-author:ChiaStephen KSK,
pubmed-author:EllardSusanS,
pubmed-author:GelmonKaren AKA,
pubmed-author:HayesMalcolmM,
pubmed-author:KenneckeHagenH,
pubmed-author:McArthurHeatherH,
pubmed-author:NorrisBrianB,
pubmed-author:OlivottoIvo AIA,
pubmed-author:SpeersCarolineC
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
112
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1437-44
|
|
pubmed:meshHeading |
pubmed-meshheading:18286526-Aged,
pubmed-meshheading:18286526-Aged, 80 and over,
pubmed-meshheading:18286526-Antineoplastic Agents, Hormonal,
pubmed-meshheading:18286526-Breast Neoplasms,
pubmed-meshheading:18286526-Carcinoma, Ductal, Breast,
pubmed-meshheading:18286526-Carcinoma, Lobular,
pubmed-meshheading:18286526-Chemotherapy, Adjuvant,
pubmed-meshheading:18286526-Cohort Studies,
pubmed-meshheading:18286526-Female,
pubmed-meshheading:18286526-Follow-Up Studies,
pubmed-meshheading:18286526-Humans,
pubmed-meshheading:18286526-Lymph Nodes,
pubmed-meshheading:18286526-Lymphatic Metastasis,
pubmed-meshheading:18286526-Middle Aged,
pubmed-meshheading:18286526-Neoplasm Recurrence, Local,
pubmed-meshheading:18286526-Postmenopause,
pubmed-meshheading:18286526-Prognosis,
pubmed-meshheading:18286526-Prospective Studies,
pubmed-meshheading:18286526-Receptors, Estrogen,
pubmed-meshheading:18286526-Tamoxifen
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Risk of early recurrence among postmenopausal women with estrogen receptor-positive early breast cancer treated with adjuvant tamoxifen.
|
|
pubmed:affiliation |
Division of Medical Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada. hkennecke@bccancer.bc.ca
|
|
pubmed:publicationType |
Journal Article
|
